Glaukos Corporation [NYSE: GKOS] loss -14.88% or -8.38 points to close at $47.93 with a heavy trading volume of 3339720 shares. The company report on July 16, 2021 that Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5.
Conference Call and Webcast Scheduled for 1:30 p.m. PDT.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2021 financial results after the market close on Thursday, August 5, 2021. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PDT (4:30 p.m. EDT) on August 5, 2021.
It opened the trading session at $50.41, the shares rose to $50.475 and dropped to $46.50, the range by which the price of stock traded the whole day. The daily chart for GKOS points out that the company has recorded -45.84% loss over the past six months. However, it is still -21.87% lower than its most recent low trading price.
If we look at the average trading volume of 451.83K shares, GKOS reached to a volume of 3339720 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Glaukos Corporation [GKOS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GKOS shares is $89.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GKOS stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Glaukos Corporation shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on July 20, 2021. The new note on the price target was released on July 14, 2021, representing the official price target for Glaukos Corporation stock.
The Average True Range (ATR) for Glaukos Corporation is set at 4.09, with the Price to Sales ratio for GKOS stock in the period of the last 12 months amounting to 9.18. The Price to Book ratio for the last quarter was 3.72, with the Price to Cash per share for the same quarter was set at 8.96.
Trading performance analysis for GKOS stock
Glaukos Corporation [GKOS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -34.85. With this latest performance, GKOS shares dropped by -41.48% in over the last four-week period, additionally sinking by -45.84% over the last 6 months – not to mention a rise of 20.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GKOS stock in for the last two-week period is set at 13.95, with the RSI for the last a single of trading hit 9.07, and the three-weeks RSI is set at 18.86 for Glaukos Corporation [GKOS]. The present Moving Average for the last 50 days of trading for this stock 76.05, while it was recorded at 55.02 for the last single week of trading, and 77.21 for the last 200 days.
Glaukos Corporation [GKOS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Glaukos Corporation [GKOS] shares currently have an operating margin of -54.92 and a Gross Margin at +58.15. Glaukos Corporation’s Net Margin is presently recorded at -53.50.
Return on Total Capital for GKOS is now -14.64, given the latest momentum, and Return on Invested Capital for the company is -14.29. Return on Equity for this stock declined to -17.95, with Return on Assets sitting at -13.20. When it comes to the capital structure of this company, Glaukos Corporation [GKOS] has a Total Debt to Total Equity ratio set at 40.75. Additionally, GKOS Total Debt to Total Capital is recorded at 28.95, with Total Debt to Total Assets ending up at 27.05. Long-Term Debt to Equity for the company is recorded at 40.57, with the Long-Term Debt to Total Capital now at 28.83.
Reflecting on the efficiency of the workforce at the company, Glaukos Corporation [GKOS] managed to generate an average of -$184,300 per employee. Receivables Turnover for the company is 6.04 with a Total Asset Turnover recorded at a value of 0.25.Glaukos Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.40.
Glaukos Corporation [GKOS]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GKOS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Glaukos Corporation go to 8.00%.
An analysis of insider ownership at Glaukos Corporation [GKOS]
There are presently around $2,362 million, in the hands of institutional investors. The top three institutional holders of GKOS stocks are: BLACKROCK INC. with ownership of 7,270,447, which is approximately 4.043% of the company’s market cap and around 1.50% of the total institutional ownership; BROWN CAPITAL MANAGEMENT LLC, holding 6,354,849 shares of the stock with an approximate value of $304.59 million in GKOS stocks shares; and BAILLIE GIFFORD & CO, currently with $286.5 million in GKOS stock with ownership of nearly 22.881% of the company’s market capitalization.
Positions in Glaukos Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 108 institutional holders increased their position in Glaukos Corporation [NYSE:GKOS] by around 3,301,937 shares. Additionally, 104 investors decreased positions by around 2,606,611 shares, while 27 investors held positions by with 43,362,865 shares. The mentioned changes placed institutional holdings at 49,271,413 shares, according to the latest SEC report filing. GKOS stock had 35 new institutional investments in for a total of 224,308 shares, while 26 institutional investors sold positions of 319,880 shares during the same period.